Suzhou Weizhixiang Food Co., Ltd.

SHSE:605089 주식 보고서

시가총액: CN¥2.9b

Suzhou Weizhixiang Food 대차 대조표 상태

재무 상태 기준 확인 5/6

Suzhou Weizhixiang Food has a total shareholder equity of CN¥1.2B and total debt of CN¥15.9M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CN¥1.3B and CN¥95.6M respectively. Suzhou Weizhixiang Food's EBIT is CN¥87.0M making its interest coverage ratio -7.6. It has cash and short-term investments of CN¥950.8M.

주요 정보

1.3%

부채 비율

CN¥15.91m

부채

이자 보상 비율-7.6x
현금CN¥950.85m
주식CN¥1.20b
총 부채CN¥95.58m
총 자산CN¥1.30b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Suzhou Weizhixiang Food (SHSE:605089) Could Be Struggling To Allocate Capital

Sep 26
Suzhou Weizhixiang Food (SHSE:605089) Could Be Struggling To Allocate Capital

Time To Worry? Analysts Are Downgrading Their Suzhou Weizhixiang Food Co., Ltd. (SHSE:605089) Outlook

Sep 02
Time To Worry? Analysts Are Downgrading Their Suzhou Weizhixiang Food Co., Ltd. (SHSE:605089) Outlook

The Consensus EPS Estimates For Suzhou Weizhixiang Food Co., Ltd. (SHSE:605089) Just Fell Dramatically

May 01
The Consensus EPS Estimates For Suzhou Weizhixiang Food Co., Ltd. (SHSE:605089) Just Fell Dramatically

Estimating The Fair Value Of Suzhou Weizhixiang Food Co., Ltd. (SHSE:605089)

Apr 17
Estimating The Fair Value Of Suzhou Weizhixiang Food Co., Ltd. (SHSE:605089)

Earnings Not Telling The Story For Suzhou Weizhixiang Food Co., Ltd. (SHSE:605089)

Mar 15
Earnings Not Telling The Story For Suzhou Weizhixiang Food Co., Ltd. (SHSE:605089)

재무 상태 분석

단기부채: 605089's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥95.4M).

장기 부채: 605089's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥142.9K).


부채 대 자본 내역 및 분석

부채 수준: 605089 has more cash than its total debt.

부채 감소: 605089's debt to equity ratio has increased from 0% to 1.3% over the past 5 years.

부채 범위: 605089's debt is well covered by operating cash flow (533.5%).

이자 보장: 605089 earns more interest than it pays, so coverage of interest payments is not a concern.


대차 대조표


건강한 기업 발견하기